EC approves nivolumab and BV for relapsed or refractory cHL
The European Commission (EC) has approved nivolumab (Opdivo®) in combination with brentuximab vedotin for the treatment of adult and pediatric patients with relapsed
Lymphoma
Aggressive B-Cell Lymphomas
News
Lymphoma
Aggressive B-Cell Lymphomas
Real-world analysis finds similar efficacy for 2nd-line axi-cel, liso-cel in R/R LBCL
The EBMT analysis was led by first author Anna Ossami Saidy of the Department of Hematology and Cell Therapy at Helios Klinikum Berlin-Buch
Lymphoma
Indolent B-Cell Lymphomas
News
Brazil regulatory agency approves tafasitamab combo in R/R follicular lymphoma
Beyond this new indication, the drug is already approved in Brazil and the European Union for relapsed or refractory diffuse large B-cell lymphoma,
Tandem Meetings 2026
Leukemia
Acute Myeloid Leukemia
Quizartinib similar to placebo in impact on AML patient-reported outcomes, QoL
Analysis of the QuANTUM-First phase 3 trial found that the impact of quizartinib on patient-reported outcomes and health-related quality of life (QoL) were
Cellular Therapy
Lymphoma
Indolent B-Cell Lymphomas
News
FDA approves subcutaneous mosunetuzumab in relapsed or refractory follicular lymphoma
The US Food and Drug Administration (FDA) approved mosunetuzumab (Lunsumio VELO), a CD20xCD3 bispecific antibody, as a subcutaneous formulation for adult patients with
SOHO UK
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
News
SOHO Insider Podcast
Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma
Gloria Iacoboni, MD, PhD, a hematologist at Vall d’Hebron University Hospital in Barcelona, Spain, spoke with Dr. James Day, a clinical research training
Community Oncology News
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
News
Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series
SOHO Insider is pleased to announce two new upcoming sessions in our Community Oncology Brown Bag Series, hosted by Loretta J. Nastoupil, MD.
Trending now
ASH 2025
Leukemia
Acute Lymphoblastic Leukemia
News
Video Interviews
Drs. Zheng and Bona discuss financial toxicity in pediatric ALL
Daniel Zheng, MD, a pediatric oncologist at the Children's Hospital of Philadelphia, and Chiara Bona, MD, a pediatric oncologist at Dana-Farber Boston Children's
SOHO UK
Leukemia
Acute Lymphoblastic Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
News
Video Interviews
Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK
Dr. Manson covers the importance of treating the underlying driver of HLH to prevent recurrence and improve patient outcomes. She also highlights resources
Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Indolent B-Cell Lymphomas
News
China NMPA approves pirtobrutinib in relapsed/refractory CLL/SLL
The approval is based on the phase 3 BRUIN CLL-321 trial, the first randomized study in patients pre-treated with a covalent BTK inhibitor.